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Abstract.  A human epithelial cell line, WISH, and a 
mouse cell line,  LB6-uPAR, transfected with the hu- 
man urokinase receptor (uPAR), both expressed high 
affinity uPAR but undetectable levels of urokinase 
(uPA). In two independent assays, binding of exoge- 
nous pro-uPA produced an up to threefold enhance- 
ment of migration.  The migration  was time and con- 
centration dependent and did not involve extracellular 
proteolysis. 
This biologic response suggested that uPAR can trig- 
ger an intracellular  signal.  Since this receptor is a 
glycosyl-phosphatidylinositol-linked protein,  we postu- 
lated that it must do so by interacting  with other pro- 
teins, among which,  by analogy to other systems, 
would be a kinase.  To test this hypothesis, we carried 
out a  solid phase capture of uPAR from WISH cell ly- 
sates using either antibodies against uPAR or pro-uPA 
adsorbed to plastic wells, followed by in vitro phos- 
phorylation of the immobilized proteins.  SDS-PAGE 
and autoradiography revealed two phosphorylated pro- 
tein bands of 47 and 55 kD. Both proteins were phos- 
phorylated on serine residues.  Partial  sequence of the 
two proteins showed a  100% homology to cytokeratin 
18 (CK18) and 8 (CK8),  respectively. A  similar pat- 
tern of phosphorylation was obtained with lysates 
from A459 cells, a lung carcinoma,  but not HL60, 
LB6-uPAR or HEp3 cell lysates, suggesting that the 
identified multiprotein uPAR-complex may be specific 
for simple epithelia.  Moreover, immunocapture with 
antibody to another glycosyl-phosphatidylinositol- 
linked protein,  CD55,  which is highly expressed in 
WISH cells, was ineffective. The kinase was tenta- 
tively identified as protein kinase C, because it was in- 
hibited by an analogue of staurosporine more specific 
for PKC and not by a  PKA or tyrosine kinase inhibi- 
tors.  The kinase was tentatively identified as PKCE be- 
cause of its resistance to PMA down-modulation,  in- 
dependence of Ca  2÷ for activity, and reaction with a 
specific anti-PKCe antibody in Western blots. Cell 
fractionation into cytosolic and particulate fractions 
revealed that all four proteins,  the kinase,  uPAR, 
CK18,  and CK8, were present in the particulate 
fraction. 
In vivo, CK8, and to a lesser degree CK18,  were 
found to be phosphorylated on serine residues.  Occu- 
pation of uPAR elicited a time-dependent increase in 
the phosphorylation intensity of CK8, a cell shape 
change and a redistribution of the cytokeratin illa- 
ments. 
These results strongly suggest that uPAR serves not 
only as an anchor for uPA but participates in a  signal 
transduction pathway resulting  in a pronounced biolog- 
ical response. 
M 
IGRATION is a function of both normal cells carry- 
ing out physiologic functions such as fertilization, 
embryogenesis, angiogenesis,  and defense mecha- 
nisms and of malignant  ceils during the metastatic process. 
A  substantial  body of evidence implicates  urokinase-type 
plasminogen  activator (uPA)  1 in cell migration  (for review 
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see Blasi,  1993). uPA is produced and secreted by most cells 
in the form of a single chain proenzyme (pro-uPA) which is 
activated by a single proteolytic cleavage, uPA converts plas- 
minogen, a zymogen present in high concentration  in plasma 
and other body fluids, into plasmin  (for review see Dano et 
al.,  1985; Vassalli et al.,  1991). This latter serine protease 
can,  directly,  or  indirectly  through  activation  of metal- 
loprotease zymogens,  cause the  degradation  of most  ex- 
tracellular matrix proteins,  thought  to be a prerequisite for 
cell migration and tissue remodeling (for review see Mignatti 
and Rifkin,  1992). Indeed, our initial  studies  (Ossowski et 
al.,  1975) indicated  that  PA participated  in the migratory 
process by plasmin generation.  Moreover, expression of uPA 
was found in migrating  cells at the edge of wounded mono- 
layers of endothelial  cells (Pepper et al.,  1987) and at focal 
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(Pollanen et al.,  1988; Hebert and Baker,  1988). Enhanced 
expression ofuPA has been shown in migrating keratinocytes 
(Morioka et al.,  1987).  In addition,  these cells possess a 
specific high affinity receptor for uPA (uPAR) which is also 
modulated  during  cell  migration  (McNeill  and  Jensen, 
1990). It is likely that the migratory properties of these cells 
are conferred, at least in part, through the expression of this 
receptor. 
uPAR has a very high affinity for the growth factor domain 
of uPA,  located in the amino-terminal  fragment of uPA A 
chain,  thus binding both pro-uPA and active uPA indepen- 
dently of the catalytic site (Vassalli  et al.,  1985; Cubellis et 
al., 1986; Appella et al., 1987). uPAR, a highly glycosylated 
313-amino acid polypeptide (Roldan et al.,  1990), is cova- 
lently attached to the plasma membrane via a COOH-ter- 
minal glycosyl-phosphatidylinositol (GPI) anchor (Ploug et 
al.,  1991). 
There  is published  evidence linking  uPA binding  to its 
specific receptor  with  enhanced  chemotaxis.  Active uPA, 
uPA  inhibited  by  diisopropylfluorophosphate  and/or  the 
amino-terminal  fragment of uPA, stimulated the migration 
of human neutrophils (Gudewicz and Gilboa, 1987), bovine 
adrenal capillary endothelial cells (Fibbi et al.,  1988), and 
a human epidermal cell line (Del Rosso et al.,  1993). 
In the present study we showed that in a cell line derived 
from simple epithelium, ligation of uPAR results in enhance- 
ment of chemokinesis. Since this interaction does not involve 
extracellular  proteolysis,  and  since uPAR is  a  GPI-linked 
protein, we postulated that intracellular signal delivery must 
proceed through interaction with other components. We now 
describe the identification of some of the proteins which may 
be a part of the signal-relaying cascade, and the biochemi- 
cal changes which may be causally linked to induction of 
migration. 
Materials and Methods 
Materials. Tissue culture medium, glutamine, and antibiotics were from 
GIBCO  BRL  (Grand Island,  NY),  trypsin from Sigma Chem.  Co.  (St 
Louis, MO), FBS from JRH Biosciences (Lenexa, KS), and plasminogen 
(Plg)-free FBS obtained after two passages of the serum through a lysine- 
Sepharose column. Tissue culture plates were from Falcon (Lincoln Park, 
N J), cytodex 2 microcarrier beads from Pharmacia LKB (Piscataway,  NJ), 
aprotinin  from  ICN  (Irvine,  CA),  protein  kinase  C  (PKC)  inhibitor 
(GF109203X)  from Calbiochem-Novabiochem (LaJolla, CA), other pro- 
tease inhibitors from Boehringer-Mannheim Corp. (Indianapolis, IN). Mi- 
crotiter well strips were from Dynatech Laboratories, Inc. (Chantilly, VA). 
Recombinant pro-uPA was a gift from Abbott Laboratories (Abbott Park, 
IL) and EGF was from Collaborative Research, Inc. (Bedford, MA). Mu- 
fine mAb against pro-uPA (IgGl and IgG2a) were purified from hybridoma 
conditioned medium. Murine mAb against human uPAR (R2)  was kindly 
provided by Dr. K. Dano (Finsen Laboratory, Copenhagen, Denmark), mu- 
rine  moAb  (IgG2a)  against CD55,  prepared by  M.  Davitz  (New  York 
University Medical Center, NY)  was a  generous gift from Dr.  M.  Fein 
(Mount Sinai School of Medicine, NY). Goat and mouse anti-human uPAR 
antibody  (Ab)  and  uPA  ELISA  were  from  American Diagnostica Inc. 
(Greenwich, CT); anti-phosphotyrosine  mAb from UBI (Lake Placid, NY); 
anti-cytokeratin 8 and  18 mAbs, and biotinylated Ab from Sigma Chem 
Co.;  rabbit  anti-protein  kinase  C~  antibody  from  GIBCO  BRL;  goat 
anti-rabbit Fc and IgG from Cappel (West Chester, PA); control mouse Ab 
(IgG1  and  IgG2a)  from  Coulter  Immunology  (Hialeah,  FL);  and 
streptavidin-FITC and rhodamine-labeled anti mouse Ab from Amersham 
Corp.  (Arlington Heights, IL).  Isotopic compounds were from Du Pont- 
NEN (Boston, MA). Polyvinylidene difluoride (PVDF) and nitrocellulose 
membranes were from Millipore Corp.  (Bedford, MA). 
lodination ofPro-uPA. Pro-uPA was iodinated using 125-I and Iodogen 
to a specific activity of 5  x  106-107 cpm/t~g of protein. 
Cells. Mouse LB6 cells transfected with human uPAR cDNA  (LB6- 
uPAR) have been previously described (Roldan et al.,  1990;  Ossowski et 
al.,  1991).  Human amnion WISH cells, A459 lung carcinoma cells, and 
HL60 cells were obtained from the American Type Culture Collection 
(Rockville, MD), HEp3 cells were as previously described (Ossowski and 
Reich,  1980).  All cells except HL60,  which were grown in RPMI, were 
grown as monolayers in DME with 10% FBS, streptomycin (200 mg/1), and 
penicillin (5  x  10  s U/l). 
Migration Assays. Microcarrier beads assay:  cytodex 2  microcarrier 
beads were prepared and the migration assay performed as described by 
Rosen et al., 1990, with some modifications. Briefly, 2  x  106 WISH cells 
were mixed into a 100-mm plastic Petri dish in 10 ml DME containing 10% 
FBS with 50 mg of beads and incubated for 3 d. Cell-coated beads were 
washed twice with DME 5 % FBS and once with DME containing 3 % of 
plasminogen-free FBS  and  100  kallikrein  international  units  (KIU)/ml 
aprotinin. Cells on beads were counted as described (Rosen et al.,  1990) 
and the bead suspension adjusted to 2  x  10  ~ cells/ml in DME containing 
3 % Pig-free FBS,  100 KIU/ml aprotinin and pro-uPA where indicated in 
the figure legend. 0.5-ml aliquots of bead suspensions were incubated in a 
24-well plate at 37°C. After 24 h, the plates were washed three times with 
PBS to remove beads and cells that have migrated from the beads to the 
plastic of the well were fixed with 1% glutaraldehyde in PBS fur 10 min 
and subsequently stained with 1% crystal violet in water for 10 min. After 
several washes with H20  the colorant associated with the cells was re- 
moved with methanol/acetic acid/H20 (30:10:60,  vol/vol/vol) and the as- 
sociated optical density read at 570 nm. Wells incubated in parallel but 
without cells, were stained and washed and served as a background for the 
determination of optical density. The number of cells/weU in the range of 
200-1,000 was directly proportional to OD units. Wounding assay: wound- 
ing  assay  was  previously  described  (Ossowski  et  al.,  1975).  Briefly, 
wounded confluent cell cultures were incubated in DME  with 3%  Pig- 
depleted FBS and 100 KIU/ml of aprotinin (as described above). The cul- 
tures were stained at different times after wounding and the number of 
migrating cells along a wound edge of 8 to 12 mm was counted by micro- 
scopic inspection. 
Determination of Pro-uPA-binding Sites. Cells plated at 1 x  105 per 
well were grown for 24-48 h, washed in serum-free medium and incubated 
with increasing concentrations of ~25I-pro-uPA for 90 rain at 40C.  Specific 
binding was determined by subtracting the radioactivity bound in presence 
of a  100-fold excess of nonradiolabeled pro-uPA. The data were analyzed 
by Scatchard transformation using the SCATFIT computer program (Man- 
son and Rodbard,  1980). 
uPA Activity and Content. The uPA activity was determined in condi- 
tioned media and cell lysates using chromogenic assay for plasmin as previ- 
ously described (Mira-y-Lopez and Ossowski, 1987). uPA antigen was mea- 
sured by ELISA according to manufacturer instructions. Alternatively, cells 
were metabolically labeled with [3sS]Methionine in 95%  methionine-free 
medium containing 1 mg/mi BSA for 20 h, followed by immunoprecipita- 
tion with specific monoclonal anti uPA antibodies and autoradiography. 
Cell Lysate Preparation. Cells from confluent monolayers were washed 
with PBS and then scraped in PBS containing 1 mM EDTA. The cell pellets 
(~107 cells) were then resuspended in 1 rill lysis buffer (10 mM Tris-HC1, 
pH 8.1, 140 mM NaC1, 2 mM EDTA, 1 mM PMSF, 100 KIU/mi aprotinin, 
0.1 mg/mi leupeptin, and 1% NP-40 or Triton X-100) and extracted at room 
temperature. In some experiments, cell suspensions were incubated fur 90 
min at 4°C in DME containing 20 mM Hepes and I mg/mi BSA in the pres- 
ence or absence of pro-uPA, before cell lysis. For sample preparation for 
Western blotting with anti-phosphotyrosine mAb, the phosphatase inhibi- 
tors NaF and Na3VO4 were added to the lysis buffer at 50 mM and 1 mM 
final concentrations, respectively. After centrifugation at 3,400 rpm for 10 
rain the supernatants were collected and assayed. In some experiments the 
cell lysates were centrifuged for 10 min at 100,000 g and the supernatants 
were used for in vitro phosphorylation. 
Capture of uPAR. 100 ~1 of immune or nonimmune gammaglobulins 
at 10-50 #g/mi, or pro-uPA atS0 #g/ml, in PBS were added to microtiter 
wells and incubated for 2 h at room temperature, or overnight at 4°C. To 
block nonspecific protein-binding sites, the wells were then coated with 1% 
BSA in PBS for 2 h at room temperature. The wells were washed three times 
with PBS containing 1% NP-40.  A  100-/~1 aliquot of cell lysate was added 
to each well and incubated for 2 h at room temperature or overnight at 4"C. 
More consistent results were obtained with a 2-h incubation. The cell ly- 
sates were then removed and the wells were washed five times with PBS 
containing 1% NP-40. 
In Vitro Phosphorylation. Following uPAR capture, the proteins im- 
mobilized in the wells were incubated with 50/~1 of a reaction mixture con- 
taining 25 mM Hepes pH 7.2, 3 mM MnC12, 0.1% NP-40 and 1-5 t~Ci of 
[~/.32p] ATP.  After incubation for 5  min at  room temperature, proteins 
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jeeted to a  10%  SDS-PAGE. The gel was dried and autoradiographed. 
In  Vivo Phosphorylation.  Semi-confluent monolayers of WISH ceils 
were washed with phosphate-free  medium containing 1 mg/ml BSA and 100 
KIU/ml aprotinin, labeled to equilibrium with 100/tCi/ml [32p]orthophos- 
phate in the same medium, and incubated for 15-120 min before the end 
of labeling with  10-SM  of pro-uPA. All cultures,  including control cul- 
tures, were washed extensively, lysed in lysis buffer (prepared as above but 
supplemented with  50  mM  NaF,  20  mM  Na  pyrophosphate,  1  mM 
Na3VO4, and 2 mM PMSF added immediately before use) for 20 rain at 
room temperature, centrifuged at low speed, and then aliquots of the super- 
natants, containing equal amounts of radioactivity, were incubated for 2 h 
at 4"C with the appropriate antibodies, followed by 30-rain incubation with 
protein A-Sepharose. After extensive washing, the Sepharose beads were 
eluted in 2 × sample buffer and heated for 5 rain at 95°C. The samples were 
electrophoresed in  10%  SDS-PAGE, and autoradiographed.  The bands 
were scanned with an LKB Ultrascan XL Enhanced Laser Densitometer. 
[J2P]Phosphoamino Acid Analysis.  By superimposing the autoradio- 
gram over the gel, areas of interest were indentified  and the phosphoproteins 
were cut out of the dried gel. Gel segments were rehydrated and digested 
with 0.1 mg/rnl trypsin in 50 mM N-ethylmorpholine at pH 8. The lyophi- 
lized tryptic peptides were hydrolyzed with 6 N HC1,  1 mg/rni phenol for 
30 rain at  150°C.  [3:P]phosphoamino acids were separated by thin layer 
high voltage electrophoresis at pH 3.5 (Cooper et al.,  1983). 
Western-blot  Analysis.  75 td-samples of cell lysates were electropho- 
resed on a 10 % SDS-PAGE under nonreducing conditions and electroblot- 
ted to nitrocellulose sheets which were subsequently blocked with 1% BSA 
in TBST buffer (10 mM Tris-HC1, pH 8.1, 150 mM NaC1, 0.05%  Tween- 
20). Phosphotyrosyl-containing  proteins were detected using anti-phospho- 
tyrosine mAb at 1 ttg/ml followed by 125I-protein A at 0.2 ~Ci/rnl in TBST 
buffer. Other proteins were detected using specific mAb at 2 ~tg/mi and re- 
vealed by alkaline phosphatase reaction. 
Cell Fractionation.  Cells were washed with ice-cold PBS and the cyto- 
solic and particulate fractions were prepared by lysing the cells (using 107 
cells/ml buffer) in ice-cold hypotonic buffer containing 20 m_M Hepes, pH 
7.4,  1 mM EDTA, 0.1 mM EGTA,  100 KIU/ml aprotinin,  1 mM PMSF, 
0.1 mg/ml leupeptin, and 25 mM sucrose. Cells were homogenized on ice 
using a Dounce glass homogenizer and the nuclei removed by a low speed 
spin (1,000 rpm for 5 rain). The homogenate was centrifuged at 100,000 g 
for 10 rain at 4°C. The supernatant (cytosolic fraction) was collected and 
the pellet (particulate fraction) was resuspended in the same volume and the 
same buffer as the cytosolic fraction. 
Protein Sequence Analysis.  Solid phase immunoprecipitation was per- 
formed as described above using 96  wells coated with polyclonal goat 
anti-uPAR antibodies. Immunoprecipitates from 16 wells were sequentially 
eluted in sample buffer and loaded in one lane of a 10% polyacrylamide gel 
(6 lanes in all). After SDS-PAGE the samples were transferred to a PVDF 
membrane and stained with 0.1%  amido black in  10%  acetic acid.  The 
stained proteins were cut off and microdigested (Fernandez et al.,  1992). 
Internal sequence analysis was done by automated Edman degradation. 
Immunofluorescence.  WISH ceils were plated at 0.5-1  ×  105 cells/ml 
and grown on coverslips for 18-36 h, then fixed briefly with 2% parafor- 
maldehyde in PBS. Aldehyde-induced fluorescence was quenched with 50 
mM NtLtC1. Immunodetection was performed using antibodies diluted in 
PBS with 0.2% BSA. When required, cells were permeabilized with 0.1% 
Triton X-100. Specifically, we used as primary antibodies mouse mAb anti- 
uPA, anti-uPAR, anti-CK8, or CK18, which were visualized in a two step 
process with biotinylated anti-mouse IgG, followed by streptavidin-FITC. 
We evaluated in the same cell the relationship between uPAR and/or CKs 
by performing a second series of immunoloealization steps with the second 
mAb detected by rhodamine-labeled anti-mouse IgG.  Cells were viewed 
and photographed with Kodak TMAX 3200 using a Zeiss Axiomat micro- 
scope equipped for epifluorescence and differential interference contrast 
(DIC, Nomarsky optics). Alternatively, to evaluate possible colocalization 
we performed simultaneous double wavelength scanning with a confocal la- 
ser scanning microscope (Leica, Inc., Deerfield, IL) at a magnification ×63 
and photographed on Ektachrome 100. Each experimental condition was 
repeated at least three times. 
Results 
Characterization  of uPAR and of uPA Content 
An epithelial cell line (WISH), derived from human amnion, 
was  examined for its ability to bind  125I-labeled pro-uPA. 
Based on Scatchard analysis of three individual experiments 
the Kd for uPA/uPAR interaction was determined to be 2.3 
(+0.8)  x  10  -1°  M  (mean  +  SD).  The mean number of 
receptors per cell was  7.1  (+1.4)  x  104. The Kd and the 
number of uPAR sites in LB6-uPAR ceils was previously 
shown to be 1.7 x  10  -1° M and 1.2  x  1@, respectively (Os- 
sowski et ai.,  1991). Brief treatment with isotonic buffer at 
pH 3, known to strip receptors of their endogenous ligands 
(Stoppelli et al.,  1986), did not change receptor number or 
its affinity, thus indicating that all receptors in both cell lines 
were free of endogenous uPA.  Indeed, cell-associated and 
secreted uPA were below the level of  detection by uPA immu- 
noprecipitation of  biosynthetically labeled cells, uPA ELISA 
and PA activity assay or by immunocytochemistry (data not 
shown). In conclusion, WISH and LB6-uPAR cells, which 
express uPAR but no detectable uPA, constitute a suitable 
model to study the effect of exogenously added uPA. 
Effect of Pro-uPA Binding to uPAR on Cell Migration 
To examine the effect  of  exogenous pro-uPA on cell migration 
we used two cell lines and two different migration assays; 
migration  into  an  area  denuded  of cells  ("wound"),  and 
migration from the surface of beads to the surface of a cul- 
ture dish. We noticed that under basal conditions WISH cells 
migrated four times more efficiently than LB6-uPAR cells 
when tested in the bead assay (data not shown). In contrast, 
WISH cells were extremely inefficient in migrating into a 
wound. 
As shown in Fig. 1 a, pro-uPA-stimulated migration from 
beads of  WISH cells in a dose-dependent way, reaching a pla- 
teau at 0.2/~g/ml with a threefold stimulation. This effect was 
time and cell number dependent (24 h of incubation and 105 
cells per sample being the best parameters, data not shown). 
Enhancement of migration required neither active uPA, nor 
plasmin, since it occurred in medium containing Plg-free se- 
rum and aprotinin, a plasmin inhibitor. Moreover, radiola- 
beled pro-uPA, incubated under conditions of the migration 
assay, and analyzed in a reduced SDS-PAGE and autoradiog- 
raphy, remained in a  single chain form (data not shown). 
Similar enhancement of migration was obtained in confluent 
cultures  of  LB6-uPAR  preincubated  with  medium  sup- 
plemented with 0.2/xg/ml of pro-uPA, wounded and stained 
after 6, 10, and 20 h of incubation. As shown in Fig. 1 b, cells 
exposed to pro-uPA migrated more efficiently than controls 
at every time point examined. In a parallel experiment, exog- 
enous pro-uPA did not affect migration of mouse LB6 cells 
expressing human uPA (Ossowski et al.,  1991),  which was 
74.9 (+8) cells per mm in control medium and 72.8 (+10.6) 
cells per mm in medium supplemented with pro-uPA. 
uPA has been reported to trigger a mitogenic response in 
the absence of any uPA-mediated proteolytic activity (Rab- 
bani et al.,  1992). We excluded the possibility that the in- 
creased number of migrating cells was a reflection of an in- 
creased cell number due to pro-uPA treatment showing that 
under conditions determined to be optimal for cell migra- 
tion, increasing concentrations (up to 0.8/~g/ml for WISH 
and up to 0.5/zg/ml for LB6-uPAR cells) of pro-uPA did not 
result in increased DNA synthesis (data not shown). 
We judged that WISH cells, in which the receptor, and any 
protein that might be associated with it, would be of the same 
species, were better suited for the analysis of signal transduc- 
tion leading to migration, than were LB6-uPAR cells, which 
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Figure 1. Effect of pro-uPA on cell migration.  (a) Dose-response 
curve for pro-uPA-stimulated  migration of WISH cells.  Migration 
was measured using the microcarrier bead assay. Cells  grown on 
beads were incubated for 24 h in presence of increasing  concentra- 
tions of pro-uPA in DB containing 3 % plasminogen-free  FBS and 
100 KIU/ml aprotinin.  Results are expressed  as % control without 
pro-uPA (mean -I- SD of  three independent  experiments).  (b) Time- 
course  of  pro-uPA-stimulated  migration  of  LB6-uPAR  cells. 
Migration  was  measured  using  the  wounding  assay.  Wounded 
monolayers were incubated  with (broken line)  or without (solid 
line) 0.2 #g/mi of pro-uPA for various  length of time.  Results  are 
expressed as number of  migrating cells/mm (mean +  SD of  two in- 
dependent  experiments  each  done  in  triplicate,  and  8-12  mm 
counted per wound). 
Figure 2. Tyrosine phosphor- 
ylation upon u-PAR clustering. 
Untreated cells were incubated 
without  antibodies  (lane  1) 
or with rat anti-mouse mAb 
(lane  2),  or anti-uPAR  mAb 
alone  (lane  7),  or  followed 
with rat anti-mouse mAb (lane 
8), to cross-link uPAR. Cells 
pretreated  with pro-uPA were 
incubated for 1 h without anti- 
bodies 0ane 4), or with mouse 
anti-uPA mAb alone (lane 5), 
or  followed  with  rat  anti- 
mouse  mAb  (lane  6).  As  a 
positive  control, WISH cells 
incubated  for 20 min with EGF (200 ng/ml) are shown in lane 3. 
Following the incubations,  the ceils were analyzed for phosphotyro- 
syl-containing  proteins by Western  blotting,  using anti-phospho- 
tyrosine antibodies. 
uPAR mAb followed by a  second,  anti-mouse  antibody,  a 
condition known to induce tyrosine phosphorylation by sev- 
eral tyrosine kinase-associated  receptors  (Stefanova et al., 
1991),  did  not  consistently  affect the  pattern  of tyrosine- 
phosphorylated proteins in WISH cells (Fig.  2,  lanes 1, 2, 
and 4-8). By contrast, binding of EGF to its receptor, used 
as a positive control, led to a pronounced increase of the in- 
tensity  of phosphotyrosine-containing  proteins  (compare 
lanes 1 and 3).  Similar results were obtained in three addi- 
tional experiments in which different methods were used to 
reveal anti-phosphotyrosine antibody binding  (not shown). 
are mouse cells transfected with human uPAR. Thus, WISH 
cells were used in all subsequent experiments. 
Examination of 13~osine Phosphorylation Involvement 
in Signaling Pathways via uPAR 
As signal transduction via transmembrane  receptors  com- 
monly involves tyrosine phosphorylation,  including several 
GPI-anchored proteins (Stefanova et al.,  1991; Thomas and 
Samelson,  1992) and uPAR in the monocytic cell line U937 
(Dumler et al.,  1993), we tested whether receptor occupancy 
also induced tyrosine phosphorylation in WISH cells.  Cells 
were preincubated with pro-uPA for various lengths of time 
(from 5 to 60 minutes) and tyrosine-phosphorylated proteins 
were visualized by Western blot using anti phosphotyrosine 
mAb. Binding of pro-uPA was never seen to cause a detect- 
able change in phosphotyrosine levels (Fig.  2,  lanes  1  and 
4). Receptor clustering, by first exposing the cells to a mouse 
Figure 3. Association of a serine kinase activity with uPAR. (a-c) 
In vitro kinase assays were performed on immobilized uPAR from 
detergent extracts of  WISH cells that had been previously incubated 
for 1.5 h at 4°C without (lanes  1 and 3) or with (lanes 2 and 4) 
10  -s M pro-uPA.  The proteins used for the solid phase capture of 
the uPAR (lanes  3 and 4 of each gel) were mouse anti-uPA mAb 
(a), pro-uPA (b), and goat polyclonal anti-uPAR antibodies  (c). As 
a nonspecific  control (lanes  1 and 2 of each gel) mouse IgG1 (a), 
BSA (b), or goat total IgG (c) were used. Phosphorylated proteins 
were  analyzed by SDS-PAGE  followed  by autoradiography.  (d) 
Phosphoamino acid analysis of proteins A (lane 1 ) and B (lane 2) 
coprecipitated with uPAR and phospholabeled in vitro.  Phospho- 
proteins  A and B were eluted from the gel, hydrolyzed, and phos- 
phoarnino  acids  separated by thin layer electrophoresis.  Positions 
of the standard phosphoamino acids as well as the position of free 
phosphate (P0 are indicated. 
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Inhibition of tyrosine phosphatases by vanadate (Jallal et al,, 
1992) increased the level of phosphorylated proteins but did 
not affect  the response of WISH cells to either pro-uPA treat- 
ment or uPAR cross-linking (not shown). 
Association of Kinase(s) with uPAR 
To capture any kinases and kinase substrates that might be 
associated with the uPAR, WISH cell lysates were subjected 
to  solid phase  immunoprecipitation with polyclonal anti- 
uPAR antibodies.  The precipitates were then reacted with 
[7-32p]ATP and the products of this in vitro phosphorylation 
reaction were analyzed by SDS-PAGE and autoradiography. 
Two bands, one of apparent molecular mass of 47 kD, desig- 
nated band A, and one of 55 kD, designated band B, were 
identified (Fig. 3 c, lane 3). Thus, at least one kinase and two 
substrates  were  specifically associated  with  uPAR.  Only 
trace amounts of phosphorylated proteins A and B were seen 
when lysate proteins, captured with preimmune IgG, were 
tested (lanes 1 and 2). The association with uPAR was also 
evident when WISH cells were preincubated with pro-uPA 
prior to capture with anti-uPAR antibodies which recognize 
both free and occupied receptors (lane 4), suggesting that, 
most likely, the association of the kinase with the receptor 
complex did not depend on receptor occupancy by pro-uPA. 
Moreover, the same pattern of in vitro phosphorylation was 
obtained when WISH cells were lysed as monolayers or, as 
has been done in most experiments, first treated with 1 mM 
EDTA in PBS and detached by scraping, and then lysed. 
These results were confirmed when anti-uPA antibodies 
were used to precipitate cell lysates. As expected, since these 
cells  produced no  detectable pro-uPA,  uPAR  and  its  as- 
sociated  kinase  activity were  recovered when  ceils  were 
treated with pro-uPA prior to cell lysate preparation (Fig. 3 
a,  compare lane 3, without pro-uPA and lane 4,  with pro- 
uPA). While no protein kinase activity was detected in cell 
lysates incubated in BSA-coated wells (lanes 1 and 2), the 
pattern of phosphorylated proteins described above was ob- 
tained when pro-uPA-coated wells were used to capture the 
complex (Fig. 3 b). In this latter case, cell lysates from pro- 
uPA-treated, or -untreated, ceils gave similar results (lanes 
3 and 4). We hypothesized that some of  the pro-uPA may dis- 
sociate from the uPAR-complex during cell lysis and incuba- 
Figure 4.  Levels of surface uPAR-bound uPA and CD55  (FACS 
analysis) in WISH cells and their effectiveness in complex forma- 
tion by immunocapture with antibodies. (a) Cells detached with 
PBS/EDTA and preincubated with 10  -8 M pro-uPA, were washed, 
resuspended in PBS with 1 mg/ml BSA and 10/zg/ml of anti-uPA 
IgG2a, nonimmune IgG2a and anti-CD55 IgG2a, incubated for 1 h 
at 4°C,  washed, and then incubated for 45  rain  in fluorescein- 
conjugated rabbit anti-mouse. The cells were washed, resuspcnded 
at  1  x  106 cells/nil  and  subjected to cytofluorometric analysis 
using a FACScan. The data were analyzed by single histogram 
statistics and the modes are shown for each analysis. Horizontal 
axes indicate log of fluorescence intensity, and vertical axes cell 
count. (b) WISH cells incubated with pro-uPA as in a, were lysed 
and subjected to immunocapture with the following moAbs and in 
vitro phosphorylation. Lane I, anti-uPA IgG1; lane 2, nonimmune 
IgG1; lane 3, anti-CD55 IgG2a; lane 4, nonimmune IgG2a; lane 5, 
anti-uPA IgG2a. 
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uPA bound to the plastic well. To investigate this, WISH cell 
lysates (25,000  cpm per well) prepared  from cells prein- 
cubated with a saturating (1.2  x  10  -s M) concentration of 
radioactively labeled pro-uPA were incubated for 2 h in wells 
coated with either pro-uPA (50 #g/ml), goat anti-uPAR, or 
mouse anti-uPA antibodies; nonimmune goat IgG and BSA 
served as negative controls. The anti-uPA antibodies cap- 
tured 6.8 % of the radioactive, lysate-associated  pro-uPA, the 
anti-uPAR 1.1%, while the radioactivity associated with pro- 
uPA-coated  wells  was  equal  to  background  (results  not 
shown).  The  finding that the anti-uPA-coated wells bind 
most radioactivity, most likely due to binding of both pro- 
uPA-uPAR complexes and free radioactive pro-uPA, attests 
to the fact that some ligand must be dissociating from the 
complex without substantially affecting the kinase activity. 
Phosphoamino acid analysis of  proteins A and B indicated 
that serine was the major labeled residue (Fig. 3 d). Thus, 
uPAR appeared to be associated with a serine kinase and two 
potential substrates, proteins A and B. 
To test the specificity of  the association between uPAR and 
the multiprotein complex, the phosphorylation pattern pro- 
duced by antibodies to another GPI-linked protein, CD55, 
was examined. FACScan cytofluorometric  analysis of WISH 
cells incubated with pro-uPA, followed either by anti-uPA or 
anti-CD55  moAbs  or  nonimmune  Ig,  and  fluorescein- 
conjugated rabbit anti-mouse IgG, showed that WISH ceils 
expressed on their surface approximately five times more 
CD55 than uPAR (compare Fig. 4 a, top and bottom). Solid 
phase  immunocapture with these moAbs,  followed by in 
vitro phosphorylation, showed that anti-uPA IgG (Fig. 4 b, 
lanes 1 IgG1, and 5 IgG2a) produced a pattern of  phosphory- 
lation similar to that produced by anti-uPAR antibodies in 
Fig. 3 c, lanes 3 and 4). In contrast, the intensity of phos- 
phorylation produced by moAbs to CD55, another strongly 
expressed GPI-linked protein, was only slightly above that 
of isotype-matched, nonimmune mouse Ig (compare Fig. 4, 
lanes 3 and 4). Further evidence in support of the specificity 
of the  observed protein phosphorylation pattern  was  ob- 
tained from experiments in which uPAR-associated proteins 
were compared in five different cell lines. Fig. 5 shows that 
only one other cell line, A459, originating, like WISH cells, 
in simple epithelium, produced a pattern similar to that of 
WISH  cells.  Lysates from  squamous  epithelial  cell  line 
HEp3,  LB6-uPAR,  and a  promyelocytic leukemia HL60, 
showed different patterns of uPAR moAb-eaptured, phos- 
phorylated proteins. Incubation of HL60 in PMA (see Fig. 
8, lane 6) or HEp3, which produces high levels of endoge- 
nous pro-uPA, in absence ofpro-uPA (lane 8) did not change 
the pattern of phosphorylation. 
To rule out that uPAR/serine kinase association was not 
secondary to cell lysis by detergents, cytosolic and particu- 
late fractions of WISH cells were prepared and tested for ki- 
nase activity after uPAR antibody capture as before (Fig. 6 
a). Phosphorylated A and B proteins were recovered almost 
exclusively in the particulate fraction (compare cell homoge- 
nate prior to fractionation, Fig. 6 a, lanes 3 and 6, with par- 
ticulate fraction, lanes 2 and 5). The cytosolic fraction con- 
tained very little or no phosphorylated proteins A  and B 
(Fig. 6 a, lanes 1 and 4). 
Several additional control experiments were performed to 
confirm the above findings. In one, the importance of uPAR 
in the complex formation was further tested by degradation 
of surface uPAR with trypsin. This treatment, known to re- 
move almost all of the uPA-binding  sites (Estreicher et al., 
1989) resulted in more than 90%  decrease of uPA binding 
in WISH cells (results not shown). As determined by phos- 
phoimager scanning, the radioactivity of bands immunopre- 
cipitated from trypsin-treated cells with anti-uPAR antibod- 
ies was reduced by 48 % (Fig. 6 b, lane 3 and 4). In another 
experiment (not shown), in which isolated cell membranes 
were treated with trypsin, the reduction was 89 %. Treatment 
of the cells with GPI-specific phospholipase C resulted in a 
Figure 5. In vitro phosphorylation following  immunocapture of ly- 
sates from different  cell lines. In vitro kinase assays  were performed 
on lysates of WISH, LB6-uPAR, A459, HEp3, and HL60 cells. 
Prior to lysis HL60 cells were incubated in medium with 1 mg/ml 
BSA without, or with 16 nM PMA. WISH, LB6-uPAR,  and HL60 
were preincubated for  1.5 h before lysis with  10  -s M pro-uPA. 
HEp3 cells were with and without pro-uPA preincubation. Lanes 
2, 3, 7, and 10, WISH cells; lane 1, A459; lane 4, LB6-uPAR;  lanes 
5 and 6, HL60 without and with PMA; lanes 8, and 9, HEp3 with- 
out and with  pro-uPA. Antibodies  used in immunocapture: lanes 1 
and 2,  goat anti-uPAR; lanes 3-10, monoclonal mouse anti-uPA 
IgG1. 
Figure 6.  (a) Cosegregation of uPAR and a serine kinase activity 
with membranes. Cytosolic fraction (lanes 1, 4, and 7), particulate 
fraction (lanes 2, 5, and 8), or cell homogenate prior to fraction- 
ation (lanes 3 and 6) were incubated in pro-uPA (lanes 1-3), anti- 
uPAR antibody (lanes 4-6), preimmune antibody (lane 7), or BSA 
(lane 8)-coated wells. After several washes, in vitro kination was 
performed and phosphorylated proteins analyzed by SDS-PAGE 
followed by  autoradiography. (b)  Effect of cell  surface uPAR 
removal by trypsin. Cells were treated with 0.025 % trypsin for 10 
min at 37°C. Proteolysis  was stopped by 0.1 mg/ml of  soybean  tryp- 
sin inhibitor. Cell  extracts from untreated (lanes 1  and  3)  or 
trypsin-treated cells (lanes 2 and 4) were incubated in wells coated 
with preimmune (lanes I and 2) or anti-uPAR  (lanes 3 and 4) anti- 
bodies and processed as above. 
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sequencing  of proteins A and 
B. Lane 1, WISH cell lysates 
were  immunoprecipitated  by 
solid  phase  immnnocapture 
using goat anti-uPAR antibod- 
ies. Proteins bound to 16 indi- 
vidual  wells,  pooled by con- 
secutive  transfer  of  sample 
buffer from well to well, were 
electrophoresed  under  non- 
reducing  conditions  in  one 
lane of a 10% SDS-PAGE and 
blotted to a PVDF membrane. 
Proteins  were  stained  with 
amido black.  Six  such lanes 
were  combined,  the  stained 
proteins were cut out, microdigested, and used for determination 
of internal  amino acid sequences.  Lane 2, in vitro kinase assay was 
performed  on  an  immunoprecipitate  from  a  single  anti-uPAR- 
coated well. Phosphorylated proteins were analyzed by SDS-PAGE 
and  autoradiography.  Note that  the  stained  and  the  radioactive 
bands comigrate. 
less marked decrease in both uPA binding and phosphoryla- 
tion of the uPAR immunoprecipitate  (data not shown). 
ldenafication of the Components of the 
uPAR Complex 
Proteins  associated  with  uPAR were  coprecipitated  along 
with  uPAR  using  a  polyclonal  anti-uPAR  antibody.  Im- 
munoprecipitates  collected  by  consecutive  transferring  of 
sample buffer through  16 individual  wells,  were submitted 
to SDS-PAGE and electroblotted. Staining of the membrane 
revealed two major uPAR-associated proteins (Fig. 7, lane/) 
which comigrated with the phosphoproteins A  and B  (lane 
2).  Pooling of six stained  lanes  (or lysates of "~50 million 
Figure 9.  Detection of the uPAR complex proteins in lysates  of 
WISH ceils by Western blotting.  Cell lysates were prepared as de- 
scribed in Materials  and Methods, electrophoresed on a 10% SDS- 
PAGE, transferred  to nitrocellulose  filter paper and blotted with the 
appropriate antibodies.  Lanes 1, 3,  6, 8, and 9 are lysates  of un- 
treated WISH cells;  lane 5 is a lysate from pro-uPA treated cells; 
lane 2 and 4, lysates of HEp3 cells; lane 7, 10 ng of purified uPAR 
from CHO cells tranSfected with a truncated uPAR eDNA. Western 
blots were revealed using: lanes  1 and 2, anti-CK18 moAb; lanes 
3 and 4, anti-CK8  moAb; lanes 5 and 6, anti-uPA moAb; lanes  7 
and 8, anti-uPAR moAb; lane 9, anti-PKCe polyclonal antibodies. 
cells) provided sufficient material  for obtaining an internal 
sequence from A and B proteins. The sequence obtained for 
A  (MQSLNDRLASYLDRVR) and B  (QRASLEAAIADA- 
EQRGELAIK) showed  100%  homology with eytokeratins 
18 and 8,  respectively. 
Since these two bands were shown to be phosphorylated 
on serines (Fig. 3 d), we wondered whether members of ki- 
nase C  or A  may be responsible for this reaction.  Addition 
of  an  analogue  of  staurosporine  (GF109203X),  a  more 
specific PKC inhibitor (Toullec et al.,  1991) at 10  -~ M  (Fig. 
8 b, lane/) or 10  -5 M  (Fig. 8 c, lane 4) to the in vitro phos- 
phorylation reaction reduced the phosphorylation intensity 
of CK8 and CK18 to background levels.  A  high concentra- 
Figure 8.  Characterization of the uPAR-associated  kinase.  WISH 
cells were incubated with, or without, 10  -~ M PMA for 24 h, and 
processed for solid phase immnnocapture and in vitro phosphoryla- 
tion. (a) Lanes 1 and 3, control; lanes 2 and 4, PMA treated.  Lanes 
1 and 2, goat anti-uPAR antibody; lanes 3 and 4, goat anti-rabbit 
IgG. (b) Lane 1, staurosporine analogue (GFI09203X) at 10  -4 M; 
lane 2, control. (c) Lane 1, control with 0.5%  DMSO in the phos- 
phorylaton mixture; lane 2, PKI (1/zg/ml); lane 3, genistein  10  -5 
M; lane 4, GFI09203X at 10  -5 M. 
Figure 10.  In vivo phosphorylation of CK8; effect of uPAR oc- 
cupancy.  WISH cells,  washed  and labeled  with 52p (100 #Ci/eul- 
ture) for a total of 4 h (see Materials  and Methods) were incubated 
for 15-120 rain before the end of labeling,  with 10  -s M pro-uPA, 
then  washed,  lysates  prepared,  uPAR captured  as described  in 
Materials  and Methods, and then analyzed by SDS-PAGE and auto- 
radiography.  The gel was exposed for 2 h, scanned, and the relative 
intensity of the CK bands measured. This experiment was repeated 
three times with essentially  similar results. 
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a tyrosine kinase inhibitor, had only minor effects (Fig. 8 c, 
lanes 2 and 3). To further characterize the kinase, lysates of 
WISH  cells  incubated  for 24  h  without  or  with  10  -7  M 
PMA were subjected to immunocapture and phosphoryla- 
tion. A member of the PKC family, PKC e, known to be as- 
sociated with  CK8  and  CK18  (Omary et al.,  1992),  was 
shown to be resistant to down-regulation by PMA treatment 
(Baxter et al.,  1992). As seen in Fig.  8 a, PMA treatment 
for 24 h yielded the same pattern and intensity of phosphor- 
ylated bands as controls (compare lanes 1 and 2). 
In Western blot, CK8 and CK18 were easily detectable in 
WISH cells, in which they participate in complex formation 
with uPAR (Fig. 9, lanes 1 and 3, respectively), but not in 
Hep3 cells (lanes 2 and 4), in which this complex was absent. 
As  expected, uPA was present only in WISH cells prein- 
cubated with pro-uPA (Fig. 9, lane 5), but not in untreated 
cells (lane 6), confirming the results obtained in ELISA and 
in  upA activity assays.  A  band  comigrating with purified 
uPAR (Fig. 9, lane 7) was also detected in WISH cell lysates 
(lane 8). Anti-PKC~ antibodies revealed a 50-kD band which 
may correspond to the catalytic fragment of PKCe (Strulo- 
vici et al.,  1991, Baxter et al.,  1992), but this band was not 
diminished by preincubation of the antibody with the immu- 
nizing peptide at twice the concentration recommended by 
the  manufacturer.  Concentrations  of the  peptide  20-fold 
greater than that used here were shown to block the binding 
of anti-PKCe antibody in Western blots (Baxter et al., 1992). 
The results of Western blotting confirmed the presence in 
WISH  cells  of  the  proteins  participating  in  the  uPAR- 
complex formation and established the validity of the anti- 
bodies used as appropriate reagents for immunocytochemi- 
cal analysis (see below). 
In Vivo Effects of  Pro-uPA Binding to uPAR on 
Cytokeratin 8 and 18 Phosphorylation  and Cytokeratin 
b~lament Organization 
To examine the effect of pro-uPA binding to uPAR complex 
in vivo WISH cells were labeled with 32-p, incubated with 
and without pro-uPA for 15-120 min, and the pattern and the 
intensity of phosphorylation of the immunocaptured uPAR 
complexes was compared using anti-CK8 mAb. Two phos- 
phorylated proteins of mol wt corresponding to those of  CK8 
and  CK18  were detected.  CK8  was  more intensely phos- 
phorylated than CK18 under all conditions. Scanning of the 
Figure 11. Immunocytochemi- 
cal localization of uPA, uPAR 
and  cytokeratins  in  WISH 
cells incubated with and with- 
out  pro-uPA.  Cells  were 
grown 18-36 h on coverslips 
and then incubated for 20 min 
with  10  -8  M  pro-uPA (A-C 
and E) or with no addition (D) 
in medium with 10 mM Hepes, 
pH 7.4, and 1 mg/ml BSA and 
100 KIU/ml aprofinin. All cov- 
erslips  were  fixed and  then 
stained without (A-C) or after 
permeabilization (D and E). 
Staining for uPAR was  with 
mouse  anti-uPAR mAb  fol- 
lowed  by  biotinylated  anti- 
mouse  IgG  and  rhodamine- 
conjugated streptavidin (A and 
C-E). A second mouse mAb, 
anti-uPA (B) or anti-CK8 (D 
and E) was then applied and 
detected  with  fluorescein- 
conjugated  anti-mouse  IgG. 
The cultures  were  examined 
with confocal microscope and 
scanned with rhodamine  op- 
tics at 525 nm and fluorescein 
optics at 475 nm. Covisualiza- 
tion of the two fluorophores is 
seen  in  C  (uPAR and uPA), 
and  D  and  E  (uPAR, CK). 
Staining with anti-CK18 mAb 
gave identical results to anti- 
CK8 (not shown). The experi- 
ment was repeated four times 
with essentially identical re- 
suits. Bar, 20 #m. 
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most doubled after 20 min of incubation with pro-uPA, and 
reached a maximum at 90 min (Fig.  10). 
An additional approach, aimed at testing the localization 
and spatial relations between the uPAR complex proteins and 
the effect of pro-uPA binding utilized immunocytochemistry 
with  double label  fluorescence and  confocal microscopy. 
WISH cells were incubated for 20 (Fig.  11) or 60 rain (Fig. 
12), without or with 10  -8 M  (or 10  -7 M, respectively) pro- 
uPA in medium with no serum.  In nonpermeabilized pro- 
uPA-treated cells, mAb to uPAR (Fig. 11 A) or to uPA (Fig. 
11  B)  produced a  homogenous staining  of the outer cell 
membrane, which at higher magnification appeared punctate 
(D and E). The images obtained by anti-uPA and anti-uPAR 
moAbs  were  entirely  superimposable,  indicating  a  full 
colocalization of these proteins (Fig.  11, A-C). WISH cells 
incubated without pro-uPA were completely negative when 
tested with mAb to uPA (results not shown). The flat mor- 
phology of control cells (Fig. 12 A) was dramatically altered 
after pro-uPA treatment (Fig.  12 B). The cells rounded up 
and their cross-sectional diameters were reduced. An identi- 
cal cell shape change was observed after only 20 min of pro- 
uPA treatment, but the proportion of  cells affected was some- 
what  smaller  (not  shown).  Confocal microscopy of cells 
incubated in absence of  pro-uPA revealed that CK8 and CK18 
formed filaments often organized in a lattice parallel to the 
surface of  the coverslip and distributed evenly throughout the 
cytoplasm  (Fig.  11  D,  arrows). In  contrast,  in  similarly 
oriented through-sections of pro-uPA-treated cells, very few 
CK8and CK18 filaments were resolvable (Fig.  11 E). The 
distribution of  uPAR did not appear to be affected by pro-uPA 
treatment (Fig.  11 D and E). Transmission fluorescent mi- 
croscopy revealed that pro-uPA treatment did not result in 
disruption of the CK filaments (results not shown), suggest- 
ing that the main change was their redistribution. Whether 
this  change  was  the cause or the result of the cell shape 
change and how it was related to the CK phosphorylation is 
at present unknown. 
The localization of PCKE was examined using polyclonal 
anti PKCe antibodies which in Western blots of WISH cells 
recognized a  band of ,050 kD  (Fig.  9,  lane 9).  Immuno- 
cytochemistry revealed only a small number of intracellular 
(found only in permeabilized cells) particles which did not 
redistribute nor showed a specific cellular localization upon 
pro-uPA treatment (not shown).  The observed pattern was 
different from the one described, in which PKC¢ was shown 
to be a membrane-associated protein (Omary et al.,  1992). 
New reagents will be required to critically assess the role of 
PKC¢. 
Discussion 
The experiments described here were designed to confirm 
the observation that binding of pro-uPA to uPAR stimulates 
cell migration, and to identify those proteins which, together 
with uPAR,  participate in the transduction of the external 
signal and in the propagation of the specific intracellular re- 
sponses. 
Using two cell lines,  LB6-uPAR and WISH, expressing 
high affinity uPAR but no detectable levels of uPA, and two 
types of assays,  migration into a  wound (Ossowski et al., 
1975) and from cytobeads (Rosen et al.,  1990), we showed 
that binding of exogenous pro-uPA to uPAR increased cell 
migration. Proteolytically  active uPA was not required as the 
enhancement was observed in absence of plasminogen and 
in presence of aprotinin. A qualitatively similar, but quan- 
titatively modest effect  on migration into a wound of  pro-uPA 
or  amino-terminal  fragment-treated  endothelial  cells  has 
been previously reported (Odekon et al., 1992). Stimulation 
of chemokinesis, similar in magnitude to that observed in 
our experiments, was reported in neutrophils (Gudewicz and 
Gilboa, 1987) and bovine endothelium (Fibbi et al.,  1988). 
Chemotaxis was also shown to be potently stimulated by uPA 
and its inactive forms in several cell types (Gudewicz and 
Gilboa,  1987;  Fibbi et al.,  1988; Del Rosso et al.,  1993). 
Combined, these findings indicate that both chemotaxis and 
chemokinesis may proceed in the absence of proteolytically 
active uPA or plasmin,  and that binding of pro-uPA elicits 
a specific biologic response which, by its very nature, must 
involve intracellular signaling.  Considering that uPA is se- 
creted by most cells in the inactive, proenzyme form, the 
ability of pro-uPA and its receptor to elicit an intracellular 
Figure 12.  The effect of pro- 
uPA treatment  on cell, shape 
changes.  Cells  were  grown 
and incubated as in legend to 
Fig. 11,  but then treated  for 
60 min  without  (A) or with 
10  -7  M  pro-uPA (B).  After 
fixation, cells were viewed  with 
Nomarsky optics and photo- 
graphed at the same magnifi- 
cation.  The control cells (A) 
were flat and thus had larger 
diameter  than  the  pro-uPA- 
treated  ceils  (B).  Similar 
changes were observed in cells 
treated for 20 min or in cells 
treated with  10  -8 M pro-uPA 
(not shown). 
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mal and tumor cells. 
Since uPAR is a GPI-linked protein anchored in the lipid 
bilayer and lacking a  cytoplasmic domain, it must be as- 
sumed that to transduce a  signal, it has to associate with 
other proteins which extend into the intracellular space. We 
sought to isolate these proteins by capturing the receptor- 
containing complex with either surface-immobilized anti- 
uPAR antibodies, or pro-uPA, or with surface-immobilized 
anti-uPA antibodies in the case of lysates of cells preexposed 
to pro-uPA. The lysates were prepared by extracting cells for 
20 rain at room temperature with 1% nonionic detergent be- 
cause it was shown that some GPI-linked proteins were in- 
soluble in 1% Triton X-100 at low temperature (Brown and 
Rose, 1991). Under the conditions used, most of the uPAR 
and, as previously shown (Omary et al., 1992),  most cyto- 
keratins were solubilized, thus reducing the possibility of 
the complex being a mixture of accidentally entrapped pro- 
teins.  This  conclusion  was  further  strengthened  by  the 
finding that supernatant of cell lysates spun at 100,000 g for 
10 min yielded the same assembly of proteins, when cap- 
tured with anti-uPAR antibodies and phosphorylation, as the 
supernatant  from low  speed  (3,400  rpm)  centrifugation. 
Also, extraction of WISH cells at 0°C, room temperature, 
or 37°C, followed by a 100,000 g, 10-rain centrifugation and 
Western blotting of the supernatants, produced uPAR bands 
of identical intensity (results not shown). This shows that 
uPAR is solubilized and that the complex with other proteins 
is stable under the conditions used. The results of in vitro 
phosphorylation of the proteins captured by this approach, 
combined with an analysis of the phosphorylated residues 
and  microsequencing  of the  two  32p-labeled proteins  al- 
lowed the conclusion that uPAR  formed a  complex with 
cytokeratins 8 and 18, and a serine kinase. A similar com- 
plex was observed in membranes of cells fractionated in ab- 
sence of detergents. The following results provide additional 
confirmation for the specificity of the observed interaction 
between uPAR, the CKs, and the kinase. A goat polyclonal 
anti-uPAR, a  mouse moAb anti-uPAR, two different anti- 
uPA moAbs, and anti-CK8 moAb all produced identical pat- 
terns of phosphorylated proteins (Figs. 3-6 and 8),  while 
goat anti-rabbit Fc, goat anti-rabbit Ig, and a mouse IgG1 
and IgG2a, or BSA were ineffective in immunocapture (Figs. 
3-6 and 8). The role of uPAR in formation of the complex 
was  further strengthened by the observation that in vitro 
phosphorylation was decreased by the reduction in cell sur- 
face uPAR either by phospholipase C (not shown) or trypsin 
(up to 90 % reduction) treatment, (Fig. 6 b). Moreover, anti- 
bodies to CD55, another GPI-linked protein which is highly 
expressed on the surface of  WISH ceils, behaved like nonim- 
mune antibodies. 
While the two phosphorylated bands were positively iden- 
tiffed as CK8 and CK18 by amino acid sequence, the defini- 
tive identity of the uPAR-associated kinase has not been es- 
tablished.  The following considerations, however,  suggest 
that it belongs to the PKC family and is possibly a  PKCe 
related isoform: (a) PKC-specific inhibitor (a staurosporine 
analogue),  and  not  PKA  or  tyrosine  kinase  inhibitors, 
blocked the in vitro phosphorylation of CK8 and CK18 (Fig. 
8).  (b) The in vitro phosphorylation of the uPAR complex 
could proceed in absence of exogenous calcium or allosteric 
activators of PKC. This is in agreement with published re- 
suits showing calcium independence of this enzyme (Schaap 
et al., 1989; Chou and Omary, 1991; Strulovici et al., 1991). 
It is of interest to note that treatment of cells with pro-uPA 
results in an increase in diacylglycerol, most likely due to 
de novo synthesis, but no mobilization of intracellular pools 
of calcium (Del Rosso et al.,  1993).  Moreover, in analogy 
to our finding, a 40-kD form of PKCe, which is the main 
form associated with cytokeratins (Omary et al., 1992), was 
shown to be independent of allosteric activators (Baxter et 
al., 1992).  (c) The activity of uPAR associated kinase from 
WISH cells pretreated for 24 h with 10  -7 M phorbol myris- 
tate acetate was not down-regulated as compared to control 
(Fig.  8).  The  resistance  to  down-regulation by  phorbol 
myristate acetate is a previously described property of PKCe 
(Strulovici et al.,  1991). (d) In permeabilized WISH cells, 
polyclonal antibodies recognizing the catalytic domain of 
PKCe produced a  specific pattern of immunostaining (not 
shown) and in Western blots identified a single band of o050 
kD (Fig. 9).  Our results, therefore, together with the evi- 
dence for a tight physical association of PKCe with cytokera- 
tins 8 and 18 and phosphorylation of these cytokeratins by 
this enzyme (Omary et al., 1992),  strongly suggest that the 
enzyme in the uPAR complex may be a PKCe-related kinase. 
The finding of a serine kinase in a complex with a GPI- 
linked protein was unexpected,  since only an association 
with tyrosine kinases was previously demonstrated (Stefa- 
nova et al., 1991; Thomas and Samelson, 1992;  Dumler et 
al.,  1993).  Our attempts to show phosphorylation on tyro- 
sine, either in response to pro-uPA binding to uPAR or to 
receptor  clustering by  mouse  anti-uPAR followed by rat 
anti-mouse antibodies, were unsuccessful both in Western 
blots (Fig.  2)  and in vivo-labeled 32p immunoprecipitates 
(not shown). The same anti-phosphotyrosine  antibodies used 
in the above experiments were effective in detecting an in- 
crease in EGF-dependent tyrosine phosphorylation in WISH 
cells. Thus, the signal transducing assembly in WISH cells 
may be unique and specific to epithelium, and possibly even 
simple epithelium. This is also suggested by the finding of 
an identical pattern of phosphorylation in lysates of human 
lung carcinoma cells (A459), which express cytokeratins 8 
and 18 (Ledinko and Constantino, 1990) but entirely differ- 
ent patterns in human squamous cell carcinoma (HEp3) and 
promyelocytic leukemia (HL-60) cell lysates (Fig. 5). 
A  direct implication of uPAR in signal transduction re- 
quires evidence linking its ligation to a dynamic, biochemi- 
cal intracellular event which is detectable earlier than in- 
creased migration or increased DNA synthesis. We used two 
approaches to examine whether such events ensued as a re- 
sult of exposure to pro-uPA:  a change in phosphorylation 
pattern or intensity, and a change in localization or distribu- 
tion of the proteins identified as members of the uPAR com- 
plex. As evidenced from Figs.  10-12 both events followed. 
In addition, incubation of cells with pro-uPA produced a 
striking change in cell shape. Although, increase in phos- 
phorylation and in redistribution of cytokeratins were most 
pronounced after 60 min of treatment, we do not yet have 
a sufficiently detailed time course which would allow us to 
conclude whether temporally, phosphorylation of cytokera- 
tin 8 preceded the change in its cellular distribution and how 
the two events related to the cell shape change. However, 
phosphorylation appears to play a role in intermediate ilia- 
merits  dynamics, inducing,  for instance,  reversible disas- 
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during mitosis (see for review Steiner and Liem, 1990). The 
confocal  immunofluorescence  analysis  revealed  that,  ex- 
posure  of cells  to pro-uPA,  under  conditions  which pre- 
vented  proteolysis,  caused  a  cell  shape  change  (Figs.  11 
and 12) associated with a redistribution of cytokeratin illa- 
ments (Fig.  I1, D  and E). Phosphorylation of cytokeratins 
in EGF-treated  rat hepatocytes was shown to be associated 
with their redistribution (Baribault  et al., 1989). In colonic 
carcinoma cells, the cytokeratins were found near the inner 
phase of the cell membrane (Omary et al.,  1992),  resem- 
bling the  effect observed  in pro-uPA  treated  WISH  cells. 
Since colonic carcinoma cells continuously produce uPA, it 
is possible that the receptor in these cells is in a state of per- 
manent "activation: 
The link between the change in cytokeratin phosphoryla- 
tion and their redistribution,  and enhanced migration is at 
present not understood. There is evidence that properly as- 
sembled cytokeratins may be essential for cells to migrate 
and to invade.  For example, transfection of a human mela- 
noma with a mutated cytokeratin CK18, resulted in disrupted 
keratin  filaments  and  reduced  migration  (Hendrix et  al., 
1992).  Likewise, retinoid-induced down regulation of cyto- 
keratin  18 in epithelial cell line, A459, was accompanied by 
a suppression of its in vitro invasive abilities (Ledinko and 
Constantino, 1990). In contrast, transfection of cytokeratins 
8 and 18 into L cells resulted in filament formation and in- 
creased migratory activity  (Chu  et al.,  1993). 
Taken together, our data show that uPAR forms a complex 
with several proteins, including a PKC, and that at least some 
members of this complex undergo chemical changes as a re- 
sult of its occupation by pro-uPA.  Whether these changes are 
causally linked to migration in WISH ceils will have to await 
the identication of all the members of this complex, most im- 
portantly the transmembrane protein, if such exists, and test- 
ing the effects of inactivation  or down-regulation of each of 
the identified proteins. 
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